Discussions of a waiver by the World Trade Organization (WTO) regarding certain intellectual property protections for prevention, containment and treatment of COVID-19 have once again put a spotlight on compulsory licensing and march-in rights. Undeniably the COVID-19 pandemic has changed our lives and the way we do things. However, discussions of compulsory licensing and march-in rights are not new. In the U.S., laws historically have been enacted that affect intellectual property rights during times when the need for technology was of utmost importance.

Congress, reacting to a holding of patent infringement liability on government contractors during World War I, enacted a statute that was later codified as 35 U.S.C. §68 (1926) and re-codified as 28 U.S.C. §1498 to protect wartime contractors from patent infringement. See, Zoltek Corp. v. U.S., 815 F.3d 1302 (Fed Cir. 2012)(describing the history of 28 U.S.C. §1498). The later re-codified and so called “Government Use Patent Law” (28 U.S.C. §1498) provided a shield from patent infringement and provided for compensation to patent owners when the U.S. government utilized their patented technology. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]